Singapore Exchange (SGX), which acquired a majority stake in Scientific Beta On January 31, 2020, has been awarded two more Exchange of the Year 2021 accolades, underscoring the strength of its client offering in helping market participants manage risk in Asia amid the upheaval in global markets. In separate announcements this week, SGX reclaimed “Derivatives Exchange of the Year” at the Asia Risk Awards and was named “Asia-Pacific Derivatives Exchange of the Year” at GlobalCapital’s Global Derivatives Awards for the eighth consecutive year.
Singapore Exchange (SGX), which acquired a majority stake in Scientific Beta On January 31, 2020, has been awarded two more Exchange of the Year 2021 accolades, underscoring the strength of its client offering in helping market participants manage risk in Asia amid the upheaval in global markets.
In separate announcements this week, SGX reclaimed “Derivatives Exchange of the Year” at the Asia Risk Awards and was named “Asia-Pacific Derivatives Exchange of the Year” at GlobalCapital’s Global Derivatives Awards for the eighth consecutive year.
Michael Syn, Head of Equities at SGX, said, “We are delighted to be recognised by the industry for rising to the challenge in an extraordinary year of global change and uncertainty. As the trusted exchange partner for navigating risk in Asia, we will continue to deliver the most liquid and efficient tools in service of our clients.”
Earlier this month, SGX was named “Commodity Exchange of the Year” by Energy Risk Asia, while Chew Sutat, who retired as SGX’s Head of Global Sales & Origination on 31 July, was given the “Lifetime Achievement Award” at the FOW Asia Capital Markets Awards.
In August, SGX won “Best FX Exchange in Asia” and “Best FX Clearing House in Asia” at the FX Markets Asia Awards, which recognises the best-in-class across the foreign exchange industry in Asia-Pacific.